Drug products: Cortimyk, Daktacort®, Daktar®, Mikonazol CCS
ATC code: D01AC02, D01AC20
Substances: miconazole, miconazole nitrate
A large amount of the studies consider treatment of vaginal infections, therefore analyses on sex or gender differences are lacking.
The present evidence concerning differences between men and women is very limited due to the indication of the substance but does not motivate differentiation in dosing or treatment.
No difference between men and women has been shown for transdermal absorption in general .
No studies with a clinically relevant sex analysis regarding effects of mikonazol have been found.
No studies with a clinically relevant sex analysis regarding adverse effects of mikonazol have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Date of litterature search: 2017-02-21
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson